World's Best Scientists 2026 revealed!
Luz Martín-Carbonero

Luz Martín-Carbonero

D-Index & Metrics

Microbiology

D-Index
53
Citations
12394
World Ranking
4057
National Ranking
125

Overview

Luz Martín-Carbonero is affiliated with Hospital Universitario La Paz in Spain and has contributed extensively to the field of medicine, particularly within epidemiology, infectious diseases, hepatology, virology, and emergency medicine. Their research portfolio includes a significant emphasis on HIV/AIDS drug development and treatment as well as hepatitis virus studies.

The scientist's main areas of study are as follows:

  • Medicine

The subfields of study covered include:

  • Epidemiology
  • Infectious Diseases
  • Hepatology
  • Virology
  • Emergency Medicine

Key topics addressed in their work are:

  • HIV/AIDS drug development and treatment
  • Hepatitis C virus research
  • HIV Research and Treatment
  • Hepatitis B Virus Studies
  • HIV-related health complications and treatments
  • Liver Disease Diagnosis and Treatment
  • HIV/AIDS Research and Interventions

The scientist has published multiple papers across prominent journals, including the following notable works:

  • Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19), 2020, Clinical Microbiology and Infection
  • Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status, 2021, Virulence
  • Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO), 2020, EBioMedicine
  • Comparison of methods and characterization of small RNAs from plasma extracellular vesicles of HIV/HCV coinfected patients, 2020, Scientific Reports
  • Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study, 2020, Journal of Antimicrobial Chemotherapy

Frequent co-authors collaborating with Luz Martín-Carbonero include:

  • Carmen Busca
  • Pablo Ryan
  • Rocío Montejano
  • José Ignacio Bernardino
  • Verónica Briz

Publication venues where the scientist has frequently published are:

  • Journal of Coloproctology
  • HIV Medicine
  • Open Forum Infectious Diseases
  • Enfermedades Infecciosas y Microbiología Clínica
  • Enfermedades infecciosas y microbiologia clinica (English ed )

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy.

    Marina Núñez;Raquel Lana;Juan Luis Mendoza;Luz Martín-Carbonero

  • Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.

    Pablo Labarga;Pablo Barreiro;Luz Martin-Carbonero;Sonia Rodriguez-Novoa

  • Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.

    Luz Martín-Carbonero;Yves Benhamou;Massimo Puoti;Juan Berenguer

  • Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients.

    Luz Martín-Carbonero;Vincent Soriano;Eulalia Valencia;Javier García-Samaniego

  • Pegylated Ifn-α2b plus ribavirin as therapy for chronic hepatitis C in Hiv-infected patients

    Mayte Pérez-Olmeda;Marina Núñez;Miriam Romero;Juan González

  • Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients

    Pablo Labarga;Vicente Soriano;María Eugenia Vispo;Javier Pinilla

  • Severe liver disease associated with prolonged exposure to antiretroviral drugs.

    Ivana Maida;Marina Núñez;Maria Jose Ríos;Luz Martín-Carbonero

  • Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia.

    Sonia Rodríguez-Nóvoa;Luz Martín-Carbonero;Pablo Barreiro;Gema González-Pardo

  • Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.

    C. Castellares;P. Barreiro;L. Martín-Carbonero;P. Labarga

  • Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine.

    Luz Martín-Carbonero;Marina Núñez;Juan González-Lahoz;Vincent Soriano

  • Risk Factors for Severe Hepatic Injury After Introduction of Highly Active Antiretroviral Therapy

    Unknown

  • Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir.

    Eugenia Vispo;Pablo Barreiro;Juan A Pineda;José A Mira

  • Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.

    Luz Martin-Carbonero;Ana Barrios;Pere Saballs;Guillem Sirera

  • Chronic Hepatitis E in HIV Patients: Rapid Progression to Cirrhosis and Response to Oral Ribavirin

    Karin Neukam;Pablo Barreiro;Juan Macías;Ana Avellón

  • Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine.

    Ana Barrios;Ana Rendón;Eugenia Negredo;Pablo Barreiro

  • Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.

    V. De Lédinghen;P. Barreiro;J. Foucher;P. Labarga

  • Directly acting antivirals against hepatitis C virus

    Vincent Soriano;Eugenia Vispo;Eva Poveda;Pablo Labarga

  • Antiretroviral-associated portal hypertension : a new clinical condition? Prevalence, predictors and outcome

    Ivana Maida;Pilar Garcia-Gasco;Giovanni Sotgiu;María José Rios

  • Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial

    Vincent Soriano;Pilar Garcia-Gasco;Eugenia Vispo;Andrés Ruiz-Sancho

  • Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.

    V Soriano;J M Miró;J García-Samaniego;J Torre-Cisneros

  • Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues.

    Luz Martín-Carbonero;Tiago Teixeira;Eva Poveda;Zulema Plaza

Frequent Co-Authors

Vincent Soriano
Vincent Soriano Universidad Internacional De La Rioja
Pablo Barreiro
Pablo Barreiro Hospital Universitario La Paz
Juan González-Lahoz
Juan González-Lahoz Instituto de Salud Carlos III
Pablo Labarga
Pablo Labarga Instituto de Salud Carlos III
Javier García-Samaniego
Javier García-Samaniego Hospital Universitario La Paz
Marina Núñez
Marina Núñez Wake Forest University
Francisco J. Blanco
Francisco J. Blanco University of A Coruña
Carmen de Mendoza
Carmen de Mendoza Instituto de Salud Carlos III
Jose R. Arribas
Jose R. Arribas Hospital Universitario La Paz
Andrzej Horban
Andrzej Horban Medical University of Warsaw

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to microbiology opens many doors to versatile career options. For those interested in healthcare, becoming a child life specialist salary with bachelor degree highlights opportunities where a strong science background enhances patient care and support roles.

Students with unique circumstances can find encouragement too. The list of degrees for felons includes options that align well with science and healthcare fields, showing that past challenges don’t have to block future success in microbiology-related professions.

Advancing in specialized areas is also possible. For example, studying microbiology can support transitions into medical roles like a functional medicine np salary, where understanding microbes plays a key role in patient treatment and holistic health approaches.

Additionally, a background in microbiology pairs well with certifications in healthcare administration, such as becoming a certified professional coder (cpc), blending science knowledge with healthcare data management to improve hospital and clinical operations.

Best Scientists Citing Luz Martín-Carbonero

Trending Scientists

Recently Published Articles